 | • レポートコード：QFJ1-4702 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、薬事規制業務の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（規制コンサルティング、法定代理人、規制書作成・発行、製品登録・臨床試験、その他サービス）、用途別市場規模（機関内、アウトソーシング）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・薬事規制業務の市場動向 ・企業の競争状況、市場シェア ・薬事規制業務の種類別市場規模と予測2016-2027（規制コンサルティング、法定代理人、規制書作成・発行、製品登録・臨床試験、その他サービス） ・薬事規制業務の用途別市場規模と予測2016-2027（機関内、アウトソーシング） ・薬事規制業務の北米市場規模2016-2027（アメリカ、カナダ） ・薬事規制業務の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・薬事規制業務のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・薬事規制業務の中南米市場規模2016-2027（メキシコ、ブラジル） ・薬事規制業務の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（QuintilesIMS、LabCor、PAREXEL、Pharmaceutical Product Development、INC RESEARCH HOLDINGS、PRA Health Sciences、ICON、Charles River、Advent International、WuXi AppTec, Inc.、Pharmaron Beijing Co., Ltd.、Hangzhou Tigermed Consulting Co.,Ltd.、Asymchem Laboratories (Tianjin) Co.,Ltd.、Accell Clinical Research, LLC.、GenPact Ltd.、Criterium, Inc.、Promedica International、Medpace、Covance、Freyr） ・結論 |
Pharmaceutical Regulatory Affairs, or Pharma Regulatory Affairs, refers to the professionals who maintain regulations from within the industry. The pharmaceutical industry is the most regulated of all industries. Regulatory affairs professionals are key, but perhaps overlooked, players in drug development. They are the primary communications link between the company and agencies such as FDA, and they are responsible for keeping up with the increasing scope and complexity of regulations. In the pharmaceutical industry, regulatory affairs professionals have expertise in the legal and regulatory environments, as well as in clinical research protocols.
Market Analysis and Insights: Global Pharmaceutical Regulatory Affairs Market
The global Pharmaceutical Regulatory Affairs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmaceutical Regulatory Affairs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmaceutical Regulatory Affairs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmaceutical Regulatory Affairs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmaceutical Regulatory Affairs market.
Global Pharmaceutical Regulatory Affairs Scope and Market Size
Pharmaceutical Regulatory Affairs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pharmaceutical Regulatory Affairs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Regulatory Consulting
Legal Representation
Regulatory Writing & Publishing
Product Registration & Clinical Trial Application
Other Services
Segment by Application
In-house
Outsourcing
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
QuintilesIMS
LabCor
PAREXEL
Pharmaceutical Product Development
INC RESEARCH HOLDINGS
PRA Health Sciences
ICON
Charles River
Advent International
WuXi AppTec, Inc.
Pharmaron Beijing Co., Ltd.
Hangzhou Tigermed Consulting Co.,Ltd.
Asymchem Laboratories (Tianjin) Co.,Ltd.
Accell Clinical Research, LLC.
GenPact Ltd.
Criterium, Inc.
Promedica International
Medpace
Covance
Freyr
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Regulatory Affairs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Regulatory Consulting
1.2.3 Legal Representation
1.2.4 Regulatory Writing & Publishing
1.2.5 Product Registration & Clinical Trial Application
1.2.6 Other Services
1.3 Market by Application
1.3.1 Global Pharmaceutical Regulatory Affairs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 In-house
1.3.3 Outsourcing
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Regulatory Affairs Market Perspective (2016-2027)
2.2 Pharmaceutical Regulatory Affairs Growth Trends by Regions
2.2.1 Pharmaceutical Regulatory Affairs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pharmaceutical Regulatory Affairs Historic Market Share by Regions (2016-2021)
2.2.3 Pharmaceutical Regulatory Affairs Forecasted Market Size by Regions (2022-2027)
2.3 Pharmaceutical Regulatory Affairs Industry Dynamic
2.3.1 Pharmaceutical Regulatory Affairs Market Trends
2.3.2 Pharmaceutical Regulatory Affairs Market Drivers
2.3.3 Pharmaceutical Regulatory Affairs Market Challenges
2.3.4 Pharmaceutical Regulatory Affairs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Regulatory Affairs Players by Revenue
3.1.1 Global Top Pharmaceutical Regulatory Affairs Players by Revenue (2016-2021)
3.1.2 Global Pharmaceutical Regulatory Affairs Revenue Market Share by Players (2016-2021)
3.2 Global Pharmaceutical Regulatory Affairs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical Regulatory Affairs Revenue
3.4 Global Pharmaceutical Regulatory Affairs Market Concentration Ratio
3.4.1 Global Pharmaceutical Regulatory Affairs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Regulatory Affairs Revenue in 2020
3.5 Pharmaceutical Regulatory Affairs Key Players Head office and Area Served
3.6 Key Players Pharmaceutical Regulatory Affairs Product Solution and Service
3.7 Date of Enter into Pharmaceutical Regulatory Affairs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Regulatory Affairs Breakdown Data by Type
4.1 Global Pharmaceutical Regulatory Affairs Historic Market Size by Type (2016-2021)
4.2 Global Pharmaceutical Regulatory Affairs Forecasted Market Size by Type (2022-2027)
5 Pharmaceutical Regulatory Affairs Breakdown Data by Application
5.1 Global Pharmaceutical Regulatory Affairs Historic Market Size by Application (2016-2021)
5.2 Global Pharmaceutical Regulatory Affairs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pharmaceutical Regulatory Affairs Market Size (2016-2027)
6.2 North America Pharmaceutical Regulatory Affairs Market Size by Type
6.2.1 North America Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021)
6.2.2 North America Pharmaceutical Regulatory Affairs Market Size by Type (2022-2027)
6.2.3 North America Pharmaceutical Regulatory Affairs Market Size by Type (2016-2027)
6.3 North America Pharmaceutical Regulatory Affairs Market Size by Application
6.3.1 North America Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021)
6.3.2 North America Pharmaceutical Regulatory Affairs Market Size by Application (2022-2027)
6.3.3 North America Pharmaceutical Regulatory Affairs Market Size by Application (2016-2027)
6.4 North America Pharmaceutical Regulatory Affairs Market Size by Country
6.4.1 North America Pharmaceutical Regulatory Affairs Market Size by Country (2016-2021)
6.4.2 North America Pharmaceutical Regulatory Affairs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Pharmaceutical Regulatory Affairs Market Size (2016-2027)
7.2 Europe Pharmaceutical Regulatory Affairs Market Size by Type
7.2.1 Europe Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021)
7.2.2 Europe Pharmaceutical Regulatory Affairs Market Size by Type (2022-2027)
7.2.3 Europe Pharmaceutical Regulatory Affairs Market Size by Type (2016-2027)
7.3 Europe Pharmaceutical Regulatory Affairs Market Size by Application
7.3.1 Europe Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021)
7.3.2 Europe Pharmaceutical Regulatory Affairs Market Size by Application (2022-2027)
7.3.3 Europe Pharmaceutical Regulatory Affairs Market Size by Application (2016-2027)
7.4 Europe Pharmaceutical Regulatory Affairs Market Size by Country
7.4.1 Europe Pharmaceutical Regulatory Affairs Market Size by Country (2016-2021)
7.4.2 Europe Pharmaceutical Regulatory Affairs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size (2016-2027)
8.2 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Type
8.2.1 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Type (2016-2027)
8.3 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Application
8.3.1 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Application (2016-2027)
8.4 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Region
8.4.1 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pharmaceutical Regulatory Affairs Market Size (2016-2027)
9.2 Latin America Pharmaceutical Regulatory Affairs Market Size by Type
9.2.1 Latin America Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021)
9.2.2 Latin America Pharmaceutical Regulatory Affairs Market Size by Type (2022-2027)
9.2.3 Latin America Pharmaceutical Regulatory Affairs Market Size by Type (2016-2027)
9.3 Latin America Pharmaceutical Regulatory Affairs Market Size by Application
9.3.1 Latin America Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021)
9.3.2 Latin America Pharmaceutical Regulatory Affairs Market Size by Application (2022-2027)
9.3.3 Latin America Pharmaceutical Regulatory Affairs Market Size by Application (2016-2027)
9.4 Latin America Pharmaceutical Regulatory Affairs Market Size by Country
9.4.1 Latin America Pharmaceutical Regulatory Affairs Market Size by Country (2016-2021)
9.4.2 Latin America Pharmaceutical Regulatory Affairs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size (2016-2027)
10.2 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Type
10.2.1 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Type (2016-2027)
10.3 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Application
10.3.1 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Application (2016-2027)
10.4 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Country
10.4.1 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 QuintilesIMS
11.1.1 QuintilesIMS Company Details
11.1.2 QuintilesIMS Business Overview
11.1.3 QuintilesIMS Pharmaceutical Regulatory Affairs Introduction
11.1.4 QuintilesIMS Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.1.5 QuintilesIMS Recent Development
11.2 LabCor
11.2.1 LabCor Company Details
11.2.2 LabCor Business Overview
11.2.3 LabCor Pharmaceutical Regulatory Affairs Introduction
11.2.4 LabCor Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.2.5 LabCor Recent Development
11.3 PAREXEL
11.3.1 PAREXEL Company Details
11.3.2 PAREXEL Business Overview
11.3.3 PAREXEL Pharmaceutical Regulatory Affairs Introduction
11.3.4 PAREXEL Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.3.5 PAREXEL Recent Development
11.4 Pharmaceutical Product Development
11.4.1 Pharmaceutical Product Development Company Details
11.4.2 Pharmaceutical Product Development Business Overview
11.4.3 Pharmaceutical Product Development Pharmaceutical Regulatory Affairs Introduction
11.4.4 Pharmaceutical Product Development Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.4.5 Pharmaceutical Product Development Recent Development
11.5 INC RESEARCH HOLDINGS
11.5.1 INC RESEARCH HOLDINGS Company Details
11.5.2 INC RESEARCH HOLDINGS Business Overview
11.5.3 INC RESEARCH HOLDINGS Pharmaceutical Regulatory Affairs Introduction
11.5.4 INC RESEARCH HOLDINGS Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.5.5 INC RESEARCH HOLDINGS Recent Development
11.6 PRA Health Sciences
11.6.1 PRA Health Sciences Company Details
11.6.2 PRA Health Sciences Business Overview
11.6.3 PRA Health Sciences Pharmaceutical Regulatory Affairs Introduction
11.6.4 PRA Health Sciences Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.6.5 PRA Health Sciences Recent Development
11.7 ICON
11.7.1 ICON Company Details
11.7.2 ICON Business Overview
11.7.3 ICON Pharmaceutical Regulatory Affairs Introduction
11.7.4 ICON Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.7.5 ICON Recent Development
11.8 Charles River
11.8.1 Charles River Company Details
11.8.2 Charles River Business Overview
11.8.3 Charles River Pharmaceutical Regulatory Affairs Introduction
11.8.4 Charles River Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.8.5 Charles River Recent Development
11.9 Advent International
11.9.1 Advent International Company Details
11.9.2 Advent International Business Overview
11.9.3 Advent International Pharmaceutical Regulatory Affairs Introduction
11.9.4 Advent International Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.9.5 Advent International Recent Development
11.10 WuXi AppTec, Inc.
11.10.1 WuXi AppTec, Inc. Company Details
11.10.2 WuXi AppTec, Inc. Business Overview
11.10.3 WuXi AppTec, Inc. Pharmaceutical Regulatory Affairs Introduction
11.10.4 WuXi AppTec, Inc. Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.10.5 WuXi AppTec, Inc. Recent Development
11.11 Pharmaron Beijing Co., Ltd.
11.11.1 Pharmaron Beijing Co., Ltd. Company Details
11.11.2 Pharmaron Beijing Co., Ltd. Business Overview
11.11.3 Pharmaron Beijing Co., Ltd. Pharmaceutical Regulatory Affairs Introduction
11.11.4 Pharmaron Beijing Co., Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.11.5 Pharmaron Beijing Co., Ltd. Recent Development
11.12 Hangzhou Tigermed Consulting Co.,Ltd.
11.12.1 Hangzhou Tigermed Consulting Co.,Ltd. Company Details
11.12.2 Hangzhou Tigermed Consulting Co.,Ltd. Business Overview
11.12.3 Hangzhou Tigermed Consulting Co.,Ltd. Pharmaceutical Regulatory Affairs Introduction
11.12.4 Hangzhou Tigermed Consulting Co.,Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.12.5 Hangzhou Tigermed Consulting Co.,Ltd. Recent Development
11.13 Asymchem Laboratories (Tianjin) Co.,Ltd.
11.13.1 Asymchem Laboratories (Tianjin) Co.,Ltd. Company Details
11.13.2 Asymchem Laboratories (Tianjin) Co.,Ltd. Business Overview
11.13.3 Asymchem Laboratories (Tianjin) Co.,Ltd. Pharmaceutical Regulatory Affairs Introduction
11.13.4 Asymchem Laboratories (Tianjin) Co.,Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.13.5 Asymchem Laboratories (Tianjin) Co.,Ltd. Recent Development
11.14 Accell Clinical Research, LLC.
11.14.1 Accell Clinical Research, LLC. Company Details
11.14.2 Accell Clinical Research, LLC. Business Overview
11.14.3 Accell Clinical Research, LLC. Pharmaceutical Regulatory Affairs Introduction
11.14.4 Accell Clinical Research, LLC. Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.14.5 Accell Clinical Research, LLC. Recent Development
11.15 GenPact Ltd.
11.15.1 GenPact Ltd. Company Details
11.15.2 GenPact Ltd. Business Overview
11.15.3 GenPact Ltd. Pharmaceutical Regulatory Affairs Introduction
11.15.4 GenPact Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.15.5 GenPact Ltd. Recent Development
11.16 Criterium, Inc.
11.16.1 Criterium, Inc. Company Details
11.16.2 Criterium, Inc. Business Overview
11.16.3 Criterium, Inc. Pharmaceutical Regulatory Affairs Introduction
11.16.4 Criterium, Inc. Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.16.5 Criterium, Inc. Recent Development
11.17 Promedica International
11.17.1 Promedica International Company Details
11.17.2 Promedica International Business Overview
11.17.3 Promedica International Pharmaceutical Regulatory Affairs Introduction
11.17.4 Promedica International Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.17.5 Promedica International Recent Development
11.18 Medpace
11.18.1 Medpace Company Details
11.18.2 Medpace Business Overview
11.18.3 Medpace Pharmaceutical Regulatory Affairs Introduction
11.18.4 Medpace Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.18.5 Medpace Recent Development
11.18 Covance
.1 Covance Company Details
.2 Covance Business Overview
.3 Covance Pharmaceutical Regulatory Affairs Introduction
.4 Covance Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
.5 Covance Recent Development
11.20 Freyr
11.20.1 Freyr Company Details
11.20.2 Freyr Business Overview
11.20.3 Freyr Pharmaceutical Regulatory Affairs Introduction
11.20.4 Freyr Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021)
11.20.5 Freyr Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Pharmaceutical Regulatory Affairs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Regulatory Consulting
Table 3. Key Players of Legal Representation
Table 4. Key Players of Regulatory Writing & Publishing
Table 5. Key Players of Product Registration & Clinical Trial Application
Table 6. Key Players of Other Services
Table 7. Global Pharmaceutical Regulatory Affairs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Pharmaceutical Regulatory Affairs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Pharmaceutical Regulatory Affairs Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Pharmaceutical Regulatory Affairs Market Share by Regions (2016-2021)
Table 11. Global Pharmaceutical Regulatory Affairs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Pharmaceutical Regulatory Affairs Market Share by Regions (2022-2027)
Table 13. Pharmaceutical Regulatory Affairs Market Trends
Table 14. Pharmaceutical Regulatory Affairs Market Drivers
Table 15. Pharmaceutical Regulatory Affairs Market Challenges
Table 16. Pharmaceutical Regulatory Affairs Market Restraints
Table 17. Global Pharmaceutical Regulatory Affairs Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Pharmaceutical Regulatory Affairs Market Share by Players (2016-2021)
Table 19. Global Top Pharmaceutical Regulatory Affairs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Regulatory Affairs as of 2020)
Table 20. Ranking of Global Top Pharmaceutical Regulatory Affairs Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Pharmaceutical Regulatory Affairs Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pharmaceutical Regulatory Affairs Product Solution and Service
Table 24. Date of Enter into Pharmaceutical Regulatory Affairs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Pharmaceutical Regulatory Affairs Revenue Market Share by Type (2016-2021)
Table 28. Global Pharmaceutical Regulatory Affairs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Pharmaceutical Regulatory Affairs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Pharmaceutical Regulatory Affairs Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Pharmaceutical Regulatory Affairs Revenue Market Share by Application (2016-2021)
Table 32. Global Pharmaceutical Regulatory Affairs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Pharmaceutical Regulatory Affairs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Pharmaceutical Regulatory Affairs Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Pharmaceutical Regulatory Affairs Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Pharmaceutical Regulatory Affairs Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Pharmaceutical Regulatory Affairs Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Pharmaceutical Regulatory Affairs Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Pharmaceutical Regulatory Affairs Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Pharmaceutical Regulatory Affairs Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Pharmaceutical Regulatory Affairs Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Pharmaceutical Regulatory Affairs Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Pharmaceutical Regulatory Affairs Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Pharmaceutical Regulatory Affairs Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Pharmaceutical Regulatory Affairs Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Pharmaceutical Regulatory Affairs Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Pharmaceutical Regulatory Affairs Market Size by Country (2022-2027) & (US$ Million)
Table 64. QuintilesIMS Company Details
Table 65. QuintilesIMS Business Overview
Table 66. QuintilesIMS Pharmaceutical Regulatory Affairs Product
Table 67. QuintilesIMS Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 68. QuintilesIMS Recent Development
Table 69. LabCor Company Details
Table 70. LabCor Business Overview
Table 71. LabCor Pharmaceutical Regulatory Affairs Product
Table 72. LabCor Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 73. LabCor Recent Development
Table 74. PAREXEL Company Details
Table 75. PAREXEL Business Overview
Table 76. PAREXEL Pharmaceutical Regulatory Affairs Product
Table 77. PAREXEL Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 78. PAREXEL Recent Development
Table 79. Pharmaceutical Product Development Company Details
Table 80. Pharmaceutical Product Development Business Overview
Table 81. Pharmaceutical Product Development Pharmaceutical Regulatory Affairs Product
Table 82. Pharmaceutical Product Development Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 83. Pharmaceutical Product Development Recent Development
Table 84. INC RESEARCH HOLDINGS Company Details
Table 85. INC RESEARCH HOLDINGS Business Overview
Table 86. INC RESEARCH HOLDINGS Pharmaceutical Regulatory Affairs Product
Table 87. INC RESEARCH HOLDINGS Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 88. INC RESEARCH HOLDINGS Recent Development
Table 89. PRA Health Sciences Company Details
Table 90. PRA Health Sciences Business Overview
Table 91. PRA Health Sciences Pharmaceutical Regulatory Affairs Product
Table 92. PRA Health Sciences Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 93. PRA Health Sciences Recent Development
Table 94. ICON Company Details
Table 95. ICON Business Overview
Table 96. ICON Pharmaceutical Regulatory Affairs Product
Table 97. ICON Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 98. ICON Recent Development
Table 99. Charles River Company Details
Table 100. Charles River Business Overview
Table 101. Charles River Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 102. Charles River Recent Development
Table 103. Advent International Company Details
Table 104. Advent International Business Overview
Table 105. Advent International Pharmaceutical Regulatory Affairs Product
Table 106. Advent International Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 107. Advent International Recent Development
Table 108. WuXi AppTec, Inc. Company Details
Table 109. WuXi AppTec, Inc. Business Overview
Table 110. WuXi AppTec, Inc. Pharmaceutical Regulatory Affairs Product
Table 111. WuXi AppTec, Inc. Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 112. WuXi AppTec, Inc. Recent Development
Table 113. Pharmaron Beijing Co., Ltd. Company Details
Table 114. Pharmaron Beijing Co., Ltd. Business Overview
Table 115. Pharmaron Beijing Co., Ltd. Pharmaceutical Regulatory Affairs Product
Table 116. Pharmaron Beijing Co., Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 117. Pharmaron Beijing Co., Ltd. Recent Development
Table 118. Hangzhou Tigermed Consulting Co.,Ltd. Company Details
Table 119. Hangzhou Tigermed Consulting Co.,Ltd. Business Overview
Table 120. Hangzhou Tigermed Consulting Co.,Ltd. Pharmaceutical Regulatory Affairs Product
Table 121. Hangzhou Tigermed Consulting Co.,Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 122. Hangzhou Tigermed Consulting Co.,Ltd. Recent Development
Table 123. Asymchem Laboratories (Tianjin) Co.,Ltd. Company Details
Table 124. Asymchem Laboratories (Tianjin) Co.,Ltd. Business Overview
Table 125. Asymchem Laboratories (Tianjin) Co.,Ltd. Pharmaceutical Regulatory Affairs Product
Table 126. Asymchem Laboratories (Tianjin) Co.,Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 127. Asymchem Laboratories (Tianjin) Co.,Ltd. Recent Development
Table 128. Accell Clinical Research, LLC. Company Details
Table 129. Accell Clinical Research, LLC. Business Overview
Table 130. Accell Clinical Research, LLC. Pharmaceutical Regulatory Affairs Product
Table 131. Accell Clinical Research, LLC. Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 132. Accell Clinical Research, LLC. Recent Development
Table 133. GenPact Ltd. Company Details
Table 134. GenPact Ltd. Business Overview
Table 135. GenPact Ltd. Pharmaceutical Regulatory Affairs Product
Table 136. GenPact Ltd. Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 137. GenPact Ltd. Recent Development
Table 138. Criterium, Inc. Company Details
Table 139. Criterium, Inc. Business Overview
Table 140. Criterium, Inc. Pharmaceutical Regulatory Affairs Product
Table 141. Criterium, Inc. Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 142. Criterium, Inc. Recent Development
Table 143. Promedica International Company Details
Table 144. Promedica International Business Overview
Table 145. Promedica International Pharmaceutical Regulatory Affairs Product
Table 146. Promedica International Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 147. Promedica International Recent Development
Table 148. Medpace Company Details
Table 149. Medpace Business Overview
Table 150. Medpace Pharmaceutical Regulatory Affairs Product
Table 151. Medpace Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 152. Medpace Recent Development
Table 153. Covance Company Details
Table 154. Covance Business Overview
Table 155. Covance Pharmaceutical Regulatory Affairs Product
Table 156. Covance Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 157. Covance Recent Development
Table 158. Freyr Company Details
Table 159. Freyr Business Overview
Table 160. Freyr Pharmaceutical Regulatory Affairs Product
Table 161. Freyr Revenue in Pharmaceutical Regulatory Affairs Business (2016-2021) & (US$ Million)
Table 162. Freyr Recent Development
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical Regulatory Affairs Market Share by Type: 2020 VS 2027
Figure 2. Regulatory Consulting Features
Figure 3. Legal Representation Features
Figure 4. Regulatory Writing & Publishing Features
Figure 5. Product Registration & Clinical Trial Application Features
Figure 6. Other Services Features
Figure 7. Global Pharmaceutical Regulatory Affairs Market Share by Application: 2020 VS 2027
Figure 8. In-house Case Studies
Figure 9. Outsourcing Case Studies
Figure 10. Pharmaceutical Regulatory Affairs Report Years Considered
Figure 11. Global Pharmaceutical Regulatory Affairs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Pharmaceutical Regulatory Affairs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Pharmaceutical Regulatory Affairs Market Share by Regions: 2020 VS 2027
Figure 14. Global Pharmaceutical Regulatory Affairs Market Share by Regions (2022-2027)
Figure 15. Global Pharmaceutical Regulatory Affairs Market Share by Players in 2020
Figure 16. Global Top Pharmaceutical Regulatory Affairs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Regulatory Affairs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Pharmaceutical Regulatory Affairs Revenue in 2020
Figure 18. Global Pharmaceutical Regulatory Affairs Revenue Market Share by Type (2016-2021)
Figure 19. Global Pharmaceutical Regulatory Affairs Revenue Market Share by Type (2022-2027)
Figure 20. North America Pharmaceutical Regulatory Affairs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Pharmaceutical Regulatory Affairs Market Share by Type (2016-2027)
Figure 22. North America Pharmaceutical Regulatory Affairs Market Share by Application (2016-2027)
Figure 23. North America Pharmaceutical Regulatory Affairs Market Share by Country (2016-2027)
Figure 24. United States Pharmaceutical Regulatory Affairs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Pharmaceutical Regulatory Affairs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Pharmaceutical Regulatory Affairs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Pharmaceutical Regulatory Affairs Market Share by Type (2016-2027)
Figure 28. Europe Pharmaceutical Regulatory Affairs Market Share by Application (2016-2027)
Figure 29. Europe Pharmaceutical Regulatory Affairs Market Share by Country (2016-2027)
Figure 30. Germany Pharmaceutical Regulatory Affairs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Pharmaceutical Regulatory Affairs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Pharmaceutical Regulatory Affairs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Pharmaceutical Regulatory Affairs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Pharmaceutical Regulatory Affairs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Pharmaceutical Regulatory Affairs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Pharmaceutical Regulatory Affairs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Pharmaceutical Regulatory Affairs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Pharmaceutical Regulatory Affairs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Pharmaceutical Regulatory Affairs Market Share by Region (2016-2027)
Figure 40. China Pharmaceutical Regulatory Affairs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Pharmaceutical Regulatory Affairs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Pharmaceutical Regulatory Affairs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Pharmaceutical Regulatory Affairs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Pharmaceutical Regulatory Affairs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Pharmaceutical Regulatory Affairs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Pharmaceutical Regulatory Affairs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Pharmaceutical Regulatory Affairs Market Share by Type (2016-2027)
Figure 48. Latin America Pharmaceutical Regulatory Affairs Market Share by Application (2016-2027)
Figure 49. Latin America Pharmaceutical Regulatory Affairs Market Share by Country (2016-2027)
Figure 50. Mexico Pharmaceutical Regulatory Affairs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Pharmaceutical Regulatory Affairs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Pharmaceutical Regulatory Affairs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Pharmaceutical Regulatory Affairs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Pharmaceutical Regulatory Affairs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Pharmaceutical Regulatory Affairs Market Share by Country (2016-2027)
Figure 56. Turkey Pharmaceutical Regulatory Affairs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Pharmaceutical Regulatory Affairs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Pharmaceutical Regulatory Affairs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. QuintilesIMS Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2016-2021)
Figure 60. LabCor Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2016-2021)
Figure 61. PAREXEL Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2016-2021)
Figure 62. Pharmaceutical Product Development Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2016-2021)
Figure 63. INC RESEARCH HOLDINGS Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2016-2021)
Figure 64. PRA Health Sciences Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2016-2021)
Figure 65. ICON Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2016-2021)
Figure 66. Charles River Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2016-2021)
Figure 67. Advent International Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2016-2021)
Figure 68. WuXi AppTec, Inc. Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2016-2021)
Figure 69. Pharmaron Beijing Co., Ltd. Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2016-2021)
Figure 70. Hangzhou Tigermed Consulting Co.,Ltd. Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2016-2021)
Figure 71. Asymchem Laboratories (Tianjin) Co.,Ltd. Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2016-2021)
Figure 72. Accell Clinical Research, LLC. Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2016-2021)
Figure 73. GenPact Ltd. Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2016-2021)
Figure 74. Criterium, Inc. Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2016-2021)
Figure 75. Promedica International Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2016-2021)
Figure 76. Medpace Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2016-2021)
Figure 77. Covance Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2016-2021)
Figure 78. Freyr Revenue Growth Rate in Pharmaceutical Regulatory Affairs Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
世界のメディカルライティング市場規模・現状・予測（2021年-2027年） Medical writing requires knowledge of the drug development process, understanding of research methodologies, and regulatory & safety guidelines. It is one of the most commonly obtained clinical services and the demand for clinical write-up has increased due to growing pressure on pharma companies to…- 世界の腫瘍臨床試験市場規模・現状・予測（2021年-2027年） Clinical trials are the final step in a long process that begins with research in a lab. Oncology trials are predominantly early-phase studies that evaluate surrogate end points and are small, single arm, and open label. Market Analysis and Insights: Global Oncology Clinical Trial Market The global …
- 世界の腎細胞がん臨床試験パイプライン市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Renal Cell Carcinoma Clinical Trial Pipeline Market The global Renal Cell Carcinoma Clinical Trial Pipeline market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy i…
- 世界の臨床試験におけるCRO市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global CRO in Clinical Trials Market The global CRO in Clinical Trials market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the repo…
- 世界の動物用CRO市場規模・現状・予測（2021年-2027年） Veterinary CROs support sponsor companies or drug manufacturers by providing assistance in veterinary clinical trial development, strategic regulatory affairs expertise, project management support for an extensive range of veterinary products, new product development, lifecycle management of existin…